
### [MONDO:0005454](http://purl.obolibrary.org/obo/MONDO_0005454)
**Label:** lung neuroendocrine neoplasm

**Subclasses:** [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0004100](http://purl.obolibrary.org/obo/MONDO_0004100) (lung mixed small cell and squamous cell carcinoma), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0006167](http://purl.obolibrary.org/obo/MONDO_0006167) (combined lung carcinoma), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0006041](http://purl.obolibrary.org/obo/MONDO_0006041) (lung carcinoid tumor), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), 

**Mapped go classes:** [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), 

**Class expressions from DL-Learner:**

- [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex) 66.67%
- [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance) 66.67%
- [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development) 66.67%
- Thing 51.11%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 34.49%
- [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex) 32.48%
- [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex) 31.10%
- [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex) 31.10%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 20.82%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) 19.99%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 19.47%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 19.33%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 19.26%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 18.96%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 18.65%


